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The objective of the present study was to identify factors correlated with the serum leptin concentration in women with knee OA.
Fifty postmenopausal Japanese women with knee OA (age: 50–88 years) were recruited in our outpatient clinic. Plain radiographs
of the knee were taken, and urine and blood samples were collected. Dual-energy X-ray absorptiometry (DXA) scanning was
performed for the whole body and lumbar spine, and factors correlated with the serum leptin concentration were identiﬁed. A
simple linear regression analysis showed that body weight, body mass index, whole-body bone mineral density (BMD), total fat
mass, and total fat percentage, but not age, height, lumbar spine BMD, lean body mass, serum and urinary bone turnover markers,
or the radiographic grade of knee OA, were signiﬁcantly correlated with the serum leptin concentration. A multiple regression
analysis showed that among these factors, only body weight and total fat mass exhibited a signiﬁcant positive correlation with the
serum leptin concentration. These results suggest that the serum leptin concentration might be related to increases in body weight
and total fat mass, but not to BMD or bone turnover markers, in postmenopausal women with OA.
1.Introduction
Leptin, the product of the ob gene, is a peptide hormone
secreted primarily by the adipocytes and plays an important
role in the regulation of body weight by centrally inhibiting
food intake and stimulating energy expenditure [1]. Leptin
enters the circulation and crosses the blood-brain barrier
to reach its primary target, receptors in the hypothalamus.
However, a clinical study has shown that the serum leptin
concentration is elevated in obese persons and is correlated
with the percentage of body fat [2]. Thus, obesity is more
likely to be caused by central mechanisms regulating food
intake and energy expenditure than by defective signaling
originating in adipocytes and aﬀecting these central mech-
anisms [2].
Leptin regulates bone metabolism [3]. Leptin decreases
bone formation and increases bone resorption via the
sympathetic nervous system [4, 5]. Conversely, circulating
leptin also regulates bone metabolism directly by binding to
leptin receptors on bone marrow stromal cells, osteoblasts,
and osteoclasts, functioning to increase osteoblast activity
and decrease osteoclast activity [6]. Clinically, the results
of cross-sectional and longitudinal cohort studies examin-
ing relationships among the serum leptin concentration,
bone mineral density (BMD), and/or bone formation and
resorption markers remain contradictory [7–9]. A recent
prospective study demonstrated that the initial serum lep-
tin concentration, together with speciﬁc-body composition
parameters, determined the loss in total and femoral neck
B M Dv a l u e si np h y s i c a l l ya c t i v eo l d e rw o m e n[ 10].
Osteoarthritis (OA) of the knee is the most common
type of arthritis and is the major cause of chronic muscu-
loskeletal pain and mobility disability in elderly populations,
representing a signiﬁcant burden on health care provision.
Well-established risk factors for OA include aging, obesity,
and female sex [11]. The serum leptin concentration is
known to be two to threefold higher in women than in
men,independentofadiposity[12].Ithasbeenhypothesized2 Arthritis
that leptin might be a systemic or local factor mediating
the metabolic link between obesity and OA and partially
accounting for the gender disparity of this disease [13].
Accordingly, leptin was speculated to mediate the
metabolic link connecting fat mass, knee OA, and BMD
in women. However, very few studies have addressed this
issue in women with knee OA. The objective of the present
study was to identify possible correlations between the
serum leptin concentration and various factors including
age, height, body weight, body mass index (BMI), BMD, lean
body mass, total fat mass, total fat percentage, bone turnover
markers, and the radiographic grade of OA in women with
knee OA.
2.SubjectsandMethods
2.1. Subjects. Postmenopausal Japanese women with OA of
the knee who visited our outpatient clinic (orthopaedics and
sports medicine clinic) in 2002 or 2003 were recruited. All
the patients had consulted experts in knee OA treatment at
our clinic because of knee pain. The diagnosis of OA of the
knee was made based on the clinical symptoms, the results
of a physical examination, and X-ray ﬁndings of the knee.
All the patients had mild, moderate, or severe OA of the knee
(grades1–4)accordingtotheKellgrenandLawrencemethod
of grading (grade 0, normal; grade 1, possible osteophytes
only; grade 2, deﬁnite osteophytes and possible joint-space
narrowing; grade 3, moderate osteophytes and/or deﬁnite
joint-space narrowing; and grade 4, large osteophytes, severe
joint-space narrowing, and/or bony sclerosis) [14]. Because
pharmacological treatments such as oral nonsteroidal anti-
inﬂammatory drugs (NSAIDs) and intra-articular injections
ofhyaluronatesareeﬀectiveforsymptomrelief[15,16],most
of the patients were receiving weekly to monthly intraarticu-
lar injections of hyaluronate sodium and/or oral NSAIDs.
After one-month of the cessation of intraarticular injec-
tions of hyaluronate sodium, dual-energy X-ray absorptiom-
etry (DXA) scanning was performed on the whole body
and the whole lumbar spine. Urine and serum samples were
collectedfromallthepatientsbetween9:00amand11:00am,
and the serum leptin and urinary and serum bone turnover
markers were measured. Factors correlated with the serum
leptin level were then determined. Informed consent was
obtained from each patient.
2.2. Measurements of Serum Leptin and Serum and Urinary
Bone Turnover Markers. The urinary levels of pyridino-
line and deoxypyridinoline were measured using high-
performanceliquidchromatography(HPLC)(normalrange:
17.7–41.9pmol/μmol Cr and 2.8–7.6nmol/mmol Cr, resp.)
[17], and the urinary levels of cross-linked N-terminal
telopeptide of type I collagen (NTX) were measured using
an enzyme-linked immunosorbent assay (ELISA) (normal
range: 9.3–54.3nM BCE/mM Cr) [17]. The serum levels
of bone-speciﬁc alkaline phosphatase (BAP) were measured
using a chemiluminescent enzyme immunoassay (CLEIA)
(normal range: 7.9–20.9U/L) [17]. The serum levels of
osteocalcin (OC) were measured using an immunora-
diometric assay (IRMA) (normal range: 3.1–12.7ng/mL).
The serum levels of leptin were measured using a radioim-
munoassay (RIA) (normal range: 2.5–21.8ng/mL).
2.3. DXA Scanning. First, DXA scanning was performed on
thewholebodyinthesupinepositionusingaNorlandXR-36
instrument (Norland, Fort Atkison, WI, USA). The BMD of
the whole body, lean body mass, total fat mass, and total fat
percentage were measured. Second, DXA scanning was also
performed on the lumbar spine in the supine position, and
the BMD of the lumbar spine (L2–L4) in the anteroposterior
view was measured.
According to the Japanese diagnostic criteria for the
diagnosis of osteoporosis [18, 19], patients with a lumbar
spine or hip BMD <70% of the young adult mean (YAM)
or of 70–80% of the YAM and a history of osteoporotic
fractures are diagnosed as having “osteoporosis”. Patients
with a lumbar spine BMD, but not a whole-body BMD,
80% of the YAM and between 70%–80% of the YAM
without any history of osteoporotic fractures are diagnosed
asbeing“normal”andhaving“osteopenia”,respectively.Data
regarding the YAM for whole-body BMD is not available.
2.4. Statistical Analysis. A simple linear regression analysis
was used to examine possible correlations between the
serum leptin level and age; body weight; height; BMI;
lumbar spine BMD; whole-body BMD; lean body mass;
total fat mass; total fat percentage; serum and urinary bone
turnover markers including serum BAP and osteocalcin
and urinary pyridinoline, deoxypyridinoline, and NTX; and
the radiographic grade of knee OA. A multiple regression
analysis was used to determine factors correlated with the
serum leptin level among the factors that were signiﬁcantly
correlated with the serum leptin level in a simple linear
regression analysis. All statistical analyses were performed
usingtheStatView-J5.0programonaWindowscomputer.A
signiﬁcance level of P<. 05 was used for all the comparisons.
3. Results
3.1. Characteristics of Study Subjects. Table 1 shows the
characteristics of the study subjects. The mean age was
66.4 years, and the mean BMI was 24.1kg/m2 (normal
range: 18.5–25.0kg/cm2), corresponding to a “normal high”
level for Japanese populations. The mean lumbar spine
BMD was 0.864g/cm2, which was 83.1% of the young
adult mean (diagnosed as “normal BMD”). The mean
radiographic grade of OA was 2.47. The mean serum leptin
level was 9.7ng/mL (within normal range). Although the
mean urinary pyridinoline and deoxypyridinoline and the
serum OC levels were within the normal ranges, the serum
BAP and urinary NTX levels were higher than the normal
ranges [17].
3.2. Correlations of Serum Leptin Level with Various Factors.
A simple linear regression analysis showed that ﬁve factors
(body weight, BMI, whole-body BMD, total fat mass, and
total fat percentage) but not age, height, lumbar spine BMD,Arthritis 3
Table 1: Characteristics of study subjects.
Mean ± SD Range
Age (years) 66.4 ±8.2 50–88
Height (m) 1.56 ±0.05 1.47–1.65
Body weight (kg) 58.4 ±8.2 44–80
Body mass index
(kg/m2)
24.1 ±3.4 16.9–33.3
Lumbar spine BMD
(g/cm2)
0.864 ±0.204 0.524–1.316
Whole body BMD
(g/cm2)
0.866 ±0.108 0.647–1.109
Lean body mass (g) 34229 ±7548 20720–64203
Total fat mass (g) 24734 ±6135 14302–41201
Total fat percent (%) 40.8 ±5.3 29.7–51.5
Serum BAP (U/L) 28.1 ±9.8 11.7–49.8
Serum OC (ng/mL) 5.7 ±2.2 1.7–11.9
Urinary
pyridinoline
(pmol/μmol Cr)
32.5 ±9.3 19.3–63.6
Urinary
deoxypyridinoline
(nmol/mmol Cr)
6.5 ±2.0 2.8–10.1
Urinary NTX (nmol
BCE/mmol Cr)
57.9 ±21.4 8.2–95.7
Serum leptin
(ng/mL)
9.7 ±4.7 1.8–21.1
Radiographic grade 2.47 ±1.00 1–4
BMD: bone mineral density, BAP: bone-speciﬁc alkaline phosphatase, OC:
osteocalcin, NTX: cross-linked N-terminal telopeptides of type I collagen,
BCE: bone collagen equivalent, Cr: creatinine.
Normal ranges of urinary pyridinoline, deoxypyridinoline, and NTX were
17.7–41.9pmol/μmol Cr and 2.8–7.6nmol/mmol Cr, and 9.3–54.3nM
BCE/mMCr,respectively.NormalrangesofserumBAP,OC,andleptinwere
7.9–20.9U/L, 3.1–12.7ng/mL, and 2.5–21.8ng/mL, respectively.
lean body mass, serum and urinary bone turnover markers,
or the radiographic grade of knee OA were signiﬁcantly
correlated with the serum leptin level (Table 2). A multiple
regression analysis showed that among these ﬁve factors,
body weight and total fat mass were signiﬁcantly correlated
with the serum leptin level (r2 = 0.859, Table 3). Figure 1
shows the correlations between the serum leptin level and
the body weight and total fat mass according to simple linear
regression analyses.
4. Discussion
The present study conﬁrmed that the serum leptin concen-
tration was signiﬁcantly correlated with the body weight
and total fat mass in postmenopausal women with knee
OA. These positive ﬁndings are consistent with the well-
known fact that the serum leptin concentration is closely
correlated with fat mass and decreases after weight loss
[20]. OA is well known to be strongly correlated with a
high BMI [20]. Gonzalez-Gay et al. [21] found a positive
correlation between BMI and serum leptin in patients with
Table 2: Correlations of serum leptin level with various factors by
simple regression analysis.
Correlation coeﬃcient P value
Age (years) −0.240 NS
Height (m) 0.162 NS
Body weight (kg) 0.792 <.0001
Body mass index
(kg/m2)
0.693 <.0001
Lumbar spine BMD
(g/cm2)
0.255 NS
Whole body BMD
(g/cm2)
0.440 .0014
Lean body mass (g) 0.189 NS
Total fat mass (g) 0.706 <.0001
Total fat percent (%) 0.511 <.0001
Serum BAP (U/L) −0.085 NS
Serum bone Gla
protein (ng/mL)
−0.267 NS
Urinary pyridinoline
(pmol/μmol Cr)
0.138 NS
Urinary
deoxypyridinoline
(nmol/mmol Cr)
0.086 NS
Urinary NTX (nmol
BCE/mmol Cr)
−0.151 NS
Radiographic grade −0.110 NS
A simple linear regression analysis was used to examine correlations of
serum leptin level with various factors. BMD: bone mineral density, BAP:
bone-speciﬁc alkaline phosphatase, NTX: cross-linked N-terminal telopep-
tides of type I collagen, BCE: bone collagen equivalent, Cr: creatinine, NS:
not signiﬁcant.
severe rheumatoid arthritis receiving tumor necrosis factor-
α (TNF-α) antagonist therapy. In the present study, a simple
linear regression analysis showed a similar correlation in
patients with knee OA.
TherelationshipbetweenobesityandOAisanimportant
public health issue. An experimental study showed that
extreme obesity arising from impaired leptin signaling
induced alterations in subchondral bone morphology with-
out increasing the incidence of knee OA, suggesting that
body fat, in and of itself, might not be a risk factor for
joint degeneration [22]. Obesity alone does not cause knee
OA, and leptin might be involved in OA because without
leptin, obesity itself does not predispose an individual to OA
[22]. Leptin receptors have been found in articular cartilage,
further implying that leptin synthesis and secretion might
play a role in OA [13]. Leptin might play a catabolic role
in cartilage metabolism and may be a disadvantage factor
involved in the pathological process of OA [23]. Thus, the
high concentration of serum leptin in obese individuals
might be associated with an increased risk of knee OA.
As a result of the eﬀects of sex hormones, the serum
leptin concentration is higher in women than in men, even
after adjustments for BMI, and this diﬀerence might be
relevant to the inﬂuence of gender on the development and4 Arthritis
Table 3: Correlations of serum leptin level with ﬁve factors by multiple regression analysis.
Regression coeﬃcient Standard error P value
Body weight (kg) 0.331 0.123 .0098
Body mass index (kg/m2) −0.119 0.283 NS
Whole body BMD (g/cm2) 1.776 4.926 NS
Total fat mass (g) 3.145E −41 .943E −4 .0275
Total fat percent (%) −0.087 0.178 NS
A multiple regression analysis was used to examine correlations of serum leptin level with ﬁve factors that had a signiﬁcant correlation by a simple regression
analysis. BMD: bone mineral density, NS: not signiﬁcant.
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Figure 1: Correlations between the serum leptin level and body weight and total fat mass. A simple linear regression analysis was used to
examine correlations of serum leptin level with body weight and total fat mass. Body weight and total fat mass had a signiﬁcant positive
correlation with serum leptin level (both P<. 0001).
frequency of OA [24]. However, the present study did not
show any signiﬁcant correlation between the serum leptin
concentration and the radiographic grade of knee OA. Thus,
the elevated serum leptin concentrations might not have
resulted in an increased risk of knee OA in our subjects.
Studies have shown that patients with knee OA might
have a higher bone mineral content (BMC) and bone size,
although the relation between knee OA and BMD remains
to be established [25–34]. However, Weiss et al. [7]s u g g e s t
that obese people might have a relatively low level of bone
loss and a decreased risk of osteoporosis. The bone-sparing
eﬀects of body weight might possibly be caused by increased
loadingontheskeleton,theincreasedproductionofestrogen
inadiposetissue,theincreasedboneformationcausedbythe
anabolic eﬀects of high levels of insulin, and/or high levels
of bone-related hormones such as leptin [7]. The present
study showed that postmenopausal women with knee OA
(mean age: 66.4 years) had a normal lumbar spine BMD
and a “normal high” BMI, despite the fact that women older
than 65 years have an increased risk of osteoporosis [35].
The normal lumbar spine BMD might partly be attributable
to the “normal high” BMI and the subsequent increases
in loading to the skeleton. The signiﬁcant correlation
between the serum leptin concentration and whole-body
BMD observed in the simple regression analysis disappeared
in a multiple regression analysis, suggesting an interaction
between body weight or total fat mass and whole-body
BMD. The urinary NTX and serum BAP levels in our
study subjects suggested that bone turnover was mildly
increased, compared with in healthy premenopausal women
[17], as a result of menopause, similar to previously reported
postmenopausal women with osteoporosis [36]. The serum
leptin concentration was not signiﬁcantly correlated with the
BMD and bone turnover markers, probably because it was
not high enough to inﬂuence bone formation and resorption
and, subsequently, the BMD.
Joint space narrowing, sclerosis of the subchondral bone,
andthepresenceofosteophytesaretypicalstructuralfeatures
of knee OA. Thus, both articular cartilage and subchondral
bone are considered to be involved in the pathogenesis of
knee OA. However, recent evidence has shown that increased
local bone turnover, decreased BMC and stiﬀness, and
trabecular bone loss have been observed in the subchondral
bone structure of knee OA [37–39]; therefore, subchondral
bone abnormalities might be a major factor in disease
progression. The Framingham Study showed that a high
BMD and BMD gain decreased the risk of radiographic
knee OA progression [40]. Thus, the subchondral bone mass
and structure and the whole-body BMD, if it inﬂuences the
subchondral bone, might be associated with the progressionArthritis 5
of knee OA. In the present study, however, no signiﬁcant
association was found between the radiographic grade of
knee OA and the lumbar spine and whole-body BMD (data
notshown),probablybecauseofthesmallsamplesizesinthe
subanalyses.
Weight loss is correlated with a decrease in the progres-
sion of OA, and the serum leptin concentration decreases
after weight loss [20]. Thus, studying the eﬀect of inter-
ventions aimed at weight loss on the progression of knee
OA, serum leptin concentration, and BMD in patients with
knee OA would be interesting. Adiponectin, an adipose-
modulated biochemical signal, might play an important role
in the maintenance of the total BMC and regional BMD
in physically active older women [10]. Thus, examining the
correlations among serum adiponectin concentration, the
radiographic grade of knee OA, BMD, body size, and fat
mass in women would also be interesting. Further research
is needed to clarify these issues.
In conclusion, the present study evaluated the serum
leptin concentration, the radiographic grade of knee OA,
BMD, body size, and fat mass in postmenopausal women
with knee OA. The serum leptin concentration and the
lumbar spine BMD were normal. However, the BMI was
“normal high,” probably because of a mild impairment in
thecentralmechanismsofleptinsignaling.Thepresentstudy
revealed that body weight and total fat mass, but not the
BMDortheradiographicgradeofOA,exhibitedasigniﬁcant
positive correlation with the serum leptin concentration in
postmenopausal women with knee OA.
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